The organic anion transporter (OAT) family: A systems biology perspective

Physiological Reviews

Volumn 95, Issue 1, 2015, Pages 83-123

  Nigam, Sanjay K ^a   Bush, Kevin T ^a   Martovetsky, Gleb ^a   Ahn, Sun Young ^a   Liu, Henry C ^a   Richard, Erin ^a   Bhatnagar, Vibha ^a   Wu, Wei ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; ARISTOLOCHIC ACID; CYCLIC NUCLEOTIDE; DIURETIC AGENT; DRUG METABOLIZING ENZYME; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MERCURY; NONSTEROID ANTIINFLAMMATORY AGENT; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 10; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 4; ORGANIC ANION TRANSPORTER 5; ORGANIC ANION TRANSPORTER 6; ORGANIC ANION TRANSPORTER 7; ORGANIC ANION TRANSPORTER 8; ORGANIC ANION TRANSPORTER 9; PENICILLIN DERIVATIVE; PROSTAGLANDIN; SEX HORMONE; STEROID; UNCLASSIFIED DRUG; URIC ACID; VITAMIN;

ARTICLE; BLOOD LEVEL; BLOOD PLACENTA BARRIER; BODY FLUID; BRAIN; BREAST MILK; CHOROID PLEXUS; HUMAN; INTESTINE; KIDNEY; KIDNEY CONCENTRATING CAPACITY; KIDNEY DISEASE; LIVER; METABOLOMICS; NONHUMAN; NUTRIENT; OLFACTORY EPITHELIUM; PLACENTA; PROTEIN EXPRESSION; REMOTE SENSING; RETINA; SIGNAL TRANSDUCTION; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; TISSUE DISTRIBUTION;

GENE EXPRESSION REGULATION; HUMANS; ORGANIC ANION TRANSPORTERS; TISSUE DISTRIBUTION;

EID: 84919784518     PISSN: 00319333     EISSN: 15221210     Source Type: Journal    
DOI: 10.1152/physrev.00025.2013     Document Type: Article

References (307)

1. Adelibieke Y, Shimizu H, Muteliefu G, Bolati D, Niwa T. Indoxyl sulfate induces endothelial cell senescence by increasing reactive oxygen species production and p53 activity. J Ren Nutr22: 86-89, 2012.
2. Ahn SY, Bhatnagar V. Update on the molecular physiology of organic anion transporters. Curr Opin Nephrol Hypertens17: 499-505, 2008.
3. Ahn SY, Eraly SA, Tsigelny I, Nigam SK. Interaction of organic cations with organic anion transporters. J Biol Chem284: 31422-31430, 2009.
4. Ahn SY, Jamshidi N, Mo ML, Wu W, Eraly SA, Dnyanmote A, Bush KT, Gallegos TF, Sweet DH, Palsson BO, Nigam SK. Linkage of organic anion transporter-1 to metabolic pathways through integrated”omics“-driven network and functional analysis. J Biol Chem286: 31522-31531, 2011.
5. Ahn SY, Nigam SK. Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis. Mol Pharmacol76: 481-490, 2009.
6. Ai M, Min S, Grosjean Y, Leblanc C, Bell R, Benton R, Suh GS. Acid sensing by the Drosophila olfactory system. Nature468: 691-695, 2010.
7. Albrecht E, Waldenberger M, Krumsiek J, Evans AM, Jeratsch U, Breier M, Adamski J, Koenig W, Zeilinger S, Fuchs C, Klopp N, Theis FJ, Wichmann HE, Suhre K, Illig T, Strauch K, Peters A, Gieger C, Kastenmuller G, Doering A, Meisinger C. Metabolite profiling reveals new insights into the regulation of serum urate in humans. Metabo-lomics10: 141-151, 2014.
8. Alebouyeh M, Takeda M, Onozato ML, Tojo A, Noshiro R, Hasannejad H, Inatomi J, Narikawa S, Huang XL, Khamdang S, Anzai N, Endou H. Expression ofhuman organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites. J Pharmacol Sci93: 430-436, 2003.
9. Aleksunes LM, Klaassen CD. Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARalpha-, and Nrf2-null mice. Drug Metab Dispos40: 1366-1379, 2012.
10. Anderson CM, Thwaites DT. Hijacking solute carriers for proton-coupled drug transport. Physiology25: 364-377, 2010.
11. Anderson GD. Developmental pharmacokinetics. Semin Pediatr Neurol17: 208-213, 2010.
12. Anzai N, Jutabha P, Amonpatumrat-Takahashi S, Sakurai H. Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies. Clin Exp Nephrol16: 89-95, 2012.
13. Anzai N, Jutabha P, Enomoto A, Yokoyama H, Nonoguchi H, Hirata T, Shiraya K, He X, Cha SH, Takeda M, Miyazaki H, Sakata T, Tomita K, Igarashi T, Kanai Y, Endou H. Functional characterization of rat organic anion transporter 5 (Slc22a19) at the apical membrane of renal proximal tubules. J Pharmacol Exp Ther315: 534-544, 2005.
14. Anzai N, Miyazaki H, Noshiro R, Khamdang S, Chairoungdua A, Shin HJ, Enomoto A, Sakamoto S, Hirata T, Tomita K, Kanai Y, Endou H. The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J Biol Chem279: 45942-45950, 2004.
15. Aoki M, Terada T, Kajiwara M, Ogasawara K, Ikai I, Ogawa O, Katsura T, Inui K. Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation. Am J Physiol Renal Physiol295: F165-F170, 2008.
16. Aouida M, Poulin R, Ramotar D. The human carnitine transporter SLC22A16 mediates high affinity uptake of the anticancer polyamine analogue bleomycin-A5. J Biol Chem285: 6275-6284, 2010.
17. Apiwattanakul N, Sekine T, Chairoungdua A, Kanai Y, Nakajima N, Sophasan S, Endou H. Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes. Mol Pharmacol55: 847-854, 1999.
18. Aronson PS. The renal proximal tubule: a model for diversity of anion exchangers and stilbene-sensitive anion transporters. Annu Rev Physiol51: 419-441, 1989.
19. Asif AR, Steffgen J, Metten M, Grunewald RW, Muller GA, Bahn A, Burckhardt G, Hagos Y. Presence of organic anion transporters 3 (OAT3) and 4 (OAT4) in human adrenocortical cells. Pflügers Arch450: 88-95, 2005.
20. Aslamkhan AG, Han YH, Yang XP, Zalups RK, Pritchard JB. Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells. Mol Pharmacol63: 590-596, 2003.
21. Atkinson RM, Currie JP, Davis B, Pratt DA, Sharpe HM, Tomich EG. Acute toxicity of cephaloridine, an antibiotic derived from cephalosporin C. Toxicol Appl Pharmacol8: 398-406, 1966.
22. Bahn A, Hagos Y, Reuter S, Balen D, Brzica H, Krick W, Burckhardt BC, Sabolic I, Burckhardt G. Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13). J Biol Chem283: 16332-16341, 2008.
23. Bahn A, Hauss A, Appenroth D, Ebbinghaus D, Hagos Y, Steinmetzer P, Burckhardt G, Fleck C. RT-PCR-based evidence for the in vivo stimulation of renal tubularp-aminohippurate (PAH) transport by triiodothyronine (T3) or dexamethasone (DEXA) in kidney tissue of immature and adult rats. Exp Toxicol Pathol54: 367-373, 2003.
24. Bahn A, Ljubojevic M, Lorenz H, Schultz C, Ghebremedhin E, Ugele B, Sabolic I, Burckhardt G, Hagos Y. Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites. Am J Physiol Cell Physiol289: C1075-C1084, 2005.
25. Bates LA, Sayialel KN, Njiraini NW, Moss CJ, Poole JH, Byrne RW. Elephants classify human ethnic groups by odor and garment color. Curr Biol17: 1938-1942, 2007.
26. Bhatnagar V, Xu G, Hamilton BA, Truong DM, Eraly SA, Wu W, Nigam SK. Analyses of 5’ regulatory region polymorphisms in human SLC22A6 (OAT1) and SLC22A8 (OAT3). J Hum Genet51: 575-580, 2006.
27. Bow DA, Perry JL, Simon JD, Pritchard JB. The impact of plasma protein binding on the renal transport of organic anions. J Pharmacol Exp Ther316: 349-355, 2006.
28. Brady KP, Dushkin H, Fornzler D, Koike T, Magner F, Her H, Gullans S, Segre GV, Green RM, Beier DR. A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse. Genomics56: 254-261, 1999.
29. Brandoni A, Hazelhoff MH, Bulacio RP, Torres AM. Expression and function of renal and hepatic organic anion transporters in extrahepatic cholestasis. World J Gastroen-terol18: 6387-6397, 2012.
30. Breljak D, Ljubojevic M, Balen D, Zlender V, Brzica H, Micek V, Kusan M, Anzai N, Sabolic I. Renal expression of organic anion transporter Oat5 in rats and mice exhibits the female-dominant sex differences. Histol Histopathol25: 1385-1402, 2010.
31. Brosens JJ, Tullet J, Varshochi R, Lam EW. Steroid receptor action. Best Pract Res Clin Obstet Gynaecol18: 265-283, 2004.
32. Buist SC, Klaassen CD. Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels. Drug Metab Dispos 32: 620-625, 2004.
33. Burckhardt BC, Burckhardt G. Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol146: 95-158, 2003.
34. Burckhardt G. Drug transport by Organic Anion Transporters (OATs). Pharmacol Ther136: 106-130, 2012.
35. Burckhardt G, Burckhardt BC. In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy. In: Drug Transporters, edited by Fromm MF and Kim RB. Berlin: Springer, 2011, p. 29-104.
36. Burnell JM, Kirby WM. Effectiveness of a new compound, benemid, in elevating serum penicillin concentrations. J Clin Invest30: 697-700, 1951.
37. Bush KT, Keller SH, Nigam SK. Genesis and reversal of the ischemic phenotype in epithelial cells. J Clin Invest106: 621-626, 2000.
38. Cha SH, Sekine T, Kusuhara H, Yu E, Kim JY, Kim DK, Sugiyama Y, Kanai Y, Endou H. Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem275: 4507-4512, 2000.
39. Chahine S, Campos A, O’Donnell MJ. Genetic knockdown of a single organic anion transporter alters the expression of functionally related genes in Malpighian tubules of Drosophila melanogaster. J Exp Biol215: 2601-2610, 2012.
40. Chahine S, Seabrooke S, O’Donnell MJ. Effects of genetic knock-down of organic anion transporter genes on secretion of fluorescent organic ions by Malpighian tubules of Drosophila melanogaster. Arch Insect Biochem Physiol81: 228-240, 2012.
41. Chen J, Terada T, Ogasawara K, Katsura T, Inui K. Adaptive responses of renal organic anion transporter 3 (OAT3) during cholestasis. Am J Physiol Renal Physiol295: F247-F252, 2008.
42. Chen L, Hong C, Chen EC, Yee SW, Xu L, Almof EU, Wen C, Fujii K, Johns SJ, Stryke D, Ferrin TE, Simko J, Chen X, Costello JF, Giacomini KM. Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3. Pharmacogenomics J 13: 110-120, 2013.
43. Cheng J, Grande JP. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease. Exp Biol Med232: 38-51, 2007.
44. Cihlar T, Ho ES. Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1. Anal Biochem283: 49-55, 2000.
45. Cohen IR. Real and artificial immune systems: computing the state of the body. Nat Rev Immunol7: 569-574, 2007.
46. Cropp CD, Komori T, Shima JE, Urban TJ, Yee SW, More SS, Giacomini KM. Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP. Mol Pharmacol73: 1151-1158, 2008.
47. Cui W, Sheng Q, Gao XZ. Artificial endocrine system and applications. In: Proceedings of the 25th Chinese Control Conference. Heilongjiang, China: Harbin, 2006, p. 1433-1437.
48. Dahlin A, Geier E, Stocker SL, Cropp CD, Grigorenko E, Bloomer M, Siegenthaler J, Xu L, Basile AS, Tang-Liu DD, Giacomini KM. Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures. Mol Pharm10: 650-663, 2013.
49. Dantzler WH, Wright SH. The molecular and cellular physiology of basolateral organic anion transport in mammalian renal tubules. Biochim Biophys Acta1618: 185-193, 2003.
50. Davidson J, Abul HT, Milton AS, Rotondo D. Cytokines and cytokine inducers stimulate prostaglandin E2entry into the brain. Pflügers Arch442: 526-533, 2001.
51. Dean S, Tang JI, Seckl JR, Nyirenda MJ. Developmental and tissue-specific regulation of hepatocyte nuclear factor 4-alpha (HNF4-alpha) isoforms in rodents. Gene Expr14: 337-344, 2010.
52. Deguchi T, Kusuhara H, Takadate A, Endou H, Otagiri M, Sugiyama Y. Characterization of uremic toxin transport by organic anion transporters in the kidney. Kidney Int65: 162-174, 2004.
53. Denker BM, Nigam SK. Molecular structure and assembly of the tight junction. Am J Physiol Renal Physiol274: F1-F9, 1998.
54. Di Giusto G, Anzai N, Ruiz ML, Endou H, Torres AM. Expression and function of Oat1 and Oat3 in rat kidney exposed to mercuric chloride. Arch Toxicol83: 887-897, 2009.
55. Di Virgilio F, Steinberg TH, Silverstein SC. Inhibition of Fura-2 sequestration and secretion with organic anion transport blockers. Cell Calcium11: 57-62, 1990.
56. DiNatale BC, Murray IA, Schroeder JC, Flaveny CA, Lahoti TS, Laurenzana EM, Omiecinski CJ, Perdew GH. Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol Sci115: 89-97, 2010.
57. Duan P, Li S, Ai N, Hu L, Welsh WJ, You G. Potent inhibitors of human organic anion transporters 1 and 3 from clinical drug libraries: discovery and molecular characterization. Mol Pharm9: 3340-3346, 2012.
58. Duan P, Li S, You G. Regulation of human organic anion transporter 4 by parathyroid hormone-related protein and protein kinase A. Int J Biochem Mol Biol3: 322-327, 2012.
59. Duan P, Li S, You G. Transmembrane peptide as potent inhibitor of oligomerization and function of human organic anion transporter 1. Mol Pharmacol79: 569-574, 2011.
60. Duan P, You G. Short-term regulation of organic anion transporters. Pharmacol Ther125: 55-61, 2010.
61. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F, Epstein CB, Frietze S, Harrow J, Kaul R, Khatun J, Lajoie BR, Landt SG, Lee BK, Pauli F, Rosenbloom KR, Sabo P, Safi A, Sanyal A, Shoresh N, Simon JM, Song L, Trinklein ND, Altshuler RC, Birney E, Brown JB, Cheng C, Djebali S, Dong X, Ernst J, Furey TS, Gerstein M, Giardine B, Greven M, Hardison RC, Harris RS, Herrero J, Hoffman MM, Iyer S, Kelllis M, Kheradpour P, Lassmann T, Li Q, Lin X, Marinov GK, Merkel A, Mortazavi A, Parker SC, Reddy TE, Rozowsky J, Schlesinger F, Thurman RE, Wang J, Ward LD, Whitfield TW, Wilder SP, Wu W, Xi HS, Yip KY, Zhuang J, Bernstein BE, Green ED, Gunter C, Snyder M, Pazin MJ, Lowdon RF, Dillon LA, Adams LB, Kelly CJ, Zhang J, Wexler JR, Good PJ, Feingold EA, Crawford GE, Dekker J, Elinitski L, Farnham PJ, Giddings MC, Gingeras TR, Guigo R, Hubbard TJ, Kellis M, Kent WJ, Lieb JD, Margu-lies EH, Myers RM, Starnatoyannopoulos JA, Tennebaum SA, Weng Z, White KP, Wold B, Yu Y, Wrobel J, Risk BA, Gunawardena HP, Kuiper HC, Maier CW, Xie L, Chen X, Mikkelsen TS, Gillespie S, Goren A, Ram O, Zhang X, Wang L, Issner R, Coyne MJ, Durham T, Ku M, Truong T, Eaton ML, Dobin A, Tanzer A, Lagarde J, Lin W, Xue C, Williams BA, Zaleski C, Roder M, Kokocinski F, Abdelhamid RF, Alioto T, Antoshechkin I, Baer MT, Batut P, Bell I, Bell K, Chakrabortty S, Chrast J, Curado J, Derrien T, Drenkow J, Dumais E, Dumais J, Duttagupta R, Fastuca M, Fejes-Toth K, Ferreira P, Foissac S, Fullwood MJ, Gao H, Gonzalez D, Gordon A, Howald C, Jha S, Johnson R, Kapranov P, King B, Kingswood C, Li G, Luo OJ, Park E, Preall JB, Presaud K, Ribeca P, Robyr D, Ruan X, Sammeth M, Sandu KS, Schaeffer L, See LH, Shahab A, Skancke J, Suzuki AM, Takahashi H, Tilgner H, Trout D, Walters N, Wang H, Hayashizaki Y, Reymond A, Antonarakis SE, Hannon GJ, Ruan Y, Carninci P, Sloan CA, Learned K, Malladi VS, Wong MC, Barber GP, Cline MS, Dreszer TR, Heitner SG, Karolchik D, Kirkup VM, Meyer LR, Long JC, Maddren M, Raney BJ, Grasfeder LL, Giresi PG, Battenhouse A, Sheffield NC, Showers KA, London D, Bhinge AA, Shestak C, Schaner MR, Kim SK, Zhang ZZ, Mieczkowski PA, Mieczkowska JO, Liu Z, McDaniell RM, Ni Y, Rashid NU, Kim MJ, Adar S, Zhang Z, Wang T, Winter D, Keefe D, Iyer VR, Sandhu KS, Zheng M, Wang P, Gertz J, Vielmetter J, Partridge EC, Varley KE, Gasper C, Bansal A, Pepke S, Jain P, Amrhein H, Bowling KM, Anaya M, Cross MK, Muratet MA, Newberry KM, McCue K, Nesmith AS, Fisher-Aylor KI, Pusey B, DeSalvo G, Parker SL, Balasubramanian S, Davis NS, Meadows SK, Eggleston T, New-berry JS, Levy SE, Absher DM, Wong WH, Blow MJ, Visel A, Pennachio LA, Elnitski L, Petrykowska HM, Abyzov A, Aken B, Barrell D, Barson G, Berry A, Bignell A, Boy-chenko V, Bussotti G, Davidson C, Despacio-Reyes G, Diekhans M, Ezkurdia I, Frank-ish A, Gilbert J, Gonzalez JM, Griffiths E, Harte R, Hendrix DA, Hunt T, Jungreis I, Kay M, Khurana E, Leng J, Lin MF, Loveland J, Lu Z, Manthravadi D, Mariotti M, Mudge J, Mukherjee G, Notredame C, Pei B, Rodriguez JM, Saunders G, Sboner A, Searle S, Sisu C, Snow C, Steward C, Tapanari E, Tress ML, van Baren MJ, Washieti S, Wilming L, Zadissa A, Zhengdong Z, Brent M, Haussler D, Valencia A, Raymond A, Addleman N, Alexander RP, Auerbach RK, Bettinger K, Bhardwaj N, Boyle AP, Cao AR, Cayting P, Charos A, Cheng Y, Eastman C, Euskirchen G, Fleming JD, Grubert F, Habegger L, Hariharan M, Harmanci A, Iyenger S, Jin VX, Karczewski KJ, Kasowski M, Lacroute P, Lam H, Larnarre-Vincent N, Lian J, Lindahl-Allen M, Min R, Miotto B, Monahan H, Moqtaderi Z, Mu XJ, O’geen H, Ouyang Z, Patacsil D, Raha D, Ramirez L, Reed B, Shi M, Slifer T, Witt H, Wu L, Xu X, Yan KK, Yang X, Struhl K, Weissman SM, Tenebaum SA, Penalva LO, Karmakar S, Bhanvadia RR, Choudhury A, Domanus M, Ma L, Moran J, Victorsen A, Auer T, Centarin L, Eichenlaub M, Gruhl F, Heerman S, Hoeckendorf B, Inoue D, Kellner T, Kirchmaier S, Mueller C, Reinhardt R, Schertel L, Schneider S, Sinn R, Wittbrodt B, Wittbrodt J, Jain G, Balasundaram G, Bates DL, Byron R, Canfield TK, Diegel MJ, Dunn D, Ebersol AK, Frum T, Garg K, Gist E, Hansen RS, Boatman L, Haugen E, Humbert R, Johnson AK, Johnson EM, Kutyavin TM, Lee K, Lotakis D, Maurano MT, Neph SJ, Neri FV, Nguyen ED, Qu H, Reynolds AP, Roach V, Rynes E, Sanchez ME, Sandstrom RS, Shafer AO, Stergachis AB, Thomas S, Vernot B, Vierstra J, Vong S, Weaver MA, Yan Y, Zhang M, Akey JA, Bender M, Dorschner MO, Groudine M, MacCoss MJ, Navas P, Stamatoyannopoulos G, Stamatoyannopoulos JA, Beal K, Brazma A, Flicek P, Johnson N, Lukk M, Luscombe NM, Sobral D, Vaquerizas JM, Batzoglou S, Sidow A, Hussami N, Kyriazopoulou-Panagiotopoulou S, Libbrecht MW, Schaub MA, Miller W, Bickel PJ, Banfai B, Boley NP, Huang H, Li JJ, Noble WS, Bilmes JA, Buske OJ, Sahu AO, Kharchenko PV, Park PJ, Baker D, Taylor J, Lochovsky L. An integrated encyclopedia of DNA elements in the human genome. Nature489: 57-74, 2012.
62. Eder K, Ringseis R. The role of peroxisome proliferator-activated receptor alpha in transcriptional regulation of novel organic cation transporters. Eur J Pharmacol628: 1-5, 2010.
63. Ekaratanawong S, Anzai N, Jutabha P, Miyazaki H, Noshiro R, Takeda M, Kanai Y, Sophasan S, Endou H. Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci94: 297-304, 2004.
64. Emami Riedmaier A, Nies AT, Schaeffeler E, Schwab M. Organic anion transporters and their implications in pharmacotherapy. Pharmacol Rev64: 421-449, 2012.
65. Engelbrecht AP. Computational Intelligence: An Introduction. Chichester, UK: Wiley, 2007, p..
66. Engstrom K, Ameer S, Bernaudat L, Drasch G, Baeuml J, Skerfving S, Bose-O’Reilly S, Broberg K. Polymorphisms in genes encoding potential mercury transporters and urine mercury concentrations in populations exposed to mercury vapor from gold mining. Environ Health Perspect121: 85-91, 2013.
67. Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature417: 447-452, 2002.
68. Eraly SA, Blantz RC, Bhatnagar V, Nigam SK. Novel aspects of renal organic anion transporters. Curr Opin Nephrol Hypertens12: 551-558, 2003.
69. Eraly SA, Bush KT, Sampogna RV, Bhatnagar V, Nigam SK. The molecular pharmacology of organic anion transporters: from DNA to FDA? Mol Pharmacol65: 479-487, 2004.
70. Eraly SA, Hamilton BA, Nigam SK. Organic anion and cation transporters occur in pairs of similar and similarly expressed genes. Biochem Biophys Res Commun300: 333-342, 2003.
71. Eraly SA, Monte JC, Nigam SK. Novel slc22 transporter homologs in fly, worm, and human clarify the phylogenyof organic anion and cation transporters. Physiol Genomics18: 12-24, 2004.
72. Eraly SA, Nigam SK. Novel human cDNAs homologous to Drosophila Orct and mammalian carnitine transporters. Biochem Biophys Res Commun297: 1159-1166, 2002.
73. Eraly SA, Vallon V, Rieg T, Gangoiti JA, Wikoff WR, Siuzdak G, Barshop BA, Nigam SK. Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics33: 180-192, 2008.
74. Eraly SA, Vallon V, Vaughn DA, Gangoiti JA, Richter K, Nagle M, Monte JC, Rieg T, Truong DM, Long JM, Barshop BA, Kaler G, Nigam SK. Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice. J Biol Chem281: 5072-5083, 2006.
75. Filakovic P, Petek Eric A, Radanovic-Grguric L. Metabolic syndrome and psychotropic medications. Med Glas9: 180-188, 2012.
76. Forrest LR, Kramer R, Ziegler C. The structural basis of secondary active transport mechanisms. Biochim Biophys Acta1807: 167-188, 2011.
77. Fujita T, Brown C, Carlson EJ, Taylor T, de la Cruz M, Johns SJ, Stryke D, Kawamoto M, Fujita K, Castro R, Chen CW, Lin ET, Brett CM, Burchard EG, Ferrin TE, Huang CC, Leabman MK, Giacomini KM. Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). Pharmacogenet Genomics15: 201-209, 2005.
78. Gallegos TF, Martovetsky G, Kouznetsova V, Bush KT, Nigam SK. Organic anion and cation SLC22”drug“transporter (Oat1, Oat3, and Oct1) regulation during development and maturation of the kidney proximal tubule. PloS One7: e40796, 2012.
79. Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, Hoffmaster KA, Ishikawa T, Keppler D, Kim RB, Lee CA, Niemi M, Polli JW, Sugiyama Y, Swaan PW, Ware JA, Wright SH, Yee SW, Zamek-Gliszczynski MJ, Zhang L. Membrane transporters in drug development. Nat Rev Drug Discov9: 215-236, 2010.
80. Gutgesell A, Ringseis R, Brandsch C, Stangl GI, Hirche F, Eder K. Peroxisome prolif-erator-activated receptor alpha and enzymes of carnitine biosynthesis in the liver are down-regulated during lactation in rats. Metabolism58: 226-232, 2009.
81. Hagos Y, Krick W, Braulke T, Muhlhausen C, Burckhardt G, Burckhardt BC. Organic anion transporters OAT1 and OAT4 mediate the high affinity transport of glutarate derivatives accumulating in patients with glutaric acidurias. Pflügers Arch457: 223-231, 2008.
82. Hagos Y, Stein D, Ugele B, Burckhardt G, Bahn A. Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J Am Soc Nephrol18: 430-439, 2007.
83. Han YF, Fan XH, Wang XJ, Sun K, Xue H, Li WJ, Wang YB, Chen JZ, Zhen YS, Zhang WL, Zhou X, Hui R. Association of intergenic polymorphism of organic anion transporter 1 and 3 genes with hypertension and blood pressure response to hydrochlo-rothiazide. Am J Hypertens24: 340-346, 2011.
84. Hao CM, Breyer MD. Physiological regulation of prostaglandins in the kidney. Annu Rev Physiol70: 357-377, 2008.
85. Hardwick JP, Eckman K, Lee YK, Abdelmegeed MA, Esterle A, Chilian WM, Chiang JY, Song BJ. Eicosanoids in metabolic syndrome. Adv Pharmacol 66: 157-266, 2013.
86. Hasegawa M, Kusuhara H, Endou H, Sugiyama Y. Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat. J Pharmacol Exp Ther305: 1087-1097, 2003.
87. Hatano R, Mukouchi H, Matsumoto Y, Kawaguchi K, Kazama I, Endo Y, Toyama H, Ejima Y, Kurosawa S, Kanai Y, Matsubara M, Asano S. Glucocorticoid mediates the transcription of OAT-PG, a kidney-specific prostaglandin transporter. Pflügers Arch466: 925-935, 2014.
88. Hatano R, Onoe K, Obara M, Matsubara M, Kanai Y, Muto S, Asano S. Sex hormones induce a gender-related difference in renal expression of a novel prostaglandin transporter, OAT-PG, influencing basal PGE2 concentration. Am J Physiol Renal Physiol302: F342-F349, 2012.
89. Heise M, Lautem A, Knapstein J, Schattenberg JM, Hoppe-Lotichius M, Foltys D, Weiler N, Zimmermann A, Schad A, Grundemann D, Otto G, Galle PR, Schuchmann M, Zimmermann T. Downregulationoforganic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance. BMC Cancer12: 109, 2012.
90. Hilgendorf C, Ahlin G, Seithel A, Artursson P, Ungell AL, Karlsson J. Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. DrugMetab Dispos35: 1333-1340,2007.
91. Hirsch GH, Hook JB. Maturation of renal organic acid transport: substrate stimulation by penicillin and p-aminohippurate (PAH). J Pharmacol Exp Ther 171: 103-108, 1970.
92. Holland IB. ABC transporters, mechanisms and biology: an overview. Essays Biochem50: 1-17, 2011.
93. Hong M, Xu W, Yoshida T, Tanaka K, Wolff DJ, Zhou F, Inouye M, You G. Human organic anion transporter hOAT1 forms homooligomers. J Biol Chem280: 32285-32290, 2005.
94. Hong YH, Nishimura Y, Hishikawa D, Tsuzuki H, Miyahara H, Gotoh C, Choi KC, Feng DD, Chen C, Lee HG, Katoh K, Roh SG, Sasaki S. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology146: 5092-5099, 2005.
95. Hook JB, Hewitt WR. Development of mechanisms for drug excretion. Am J Med62: 497-506, 1977.
96. Hosoya K, Makihara A, Tsujikawa Y, Yoneyama D, Mori S, Terasaki T, Akanuma S, Tomi M, Tachikawa M. Roles of inner blood-retinal barrier organic anion transporter 3 in the vitreous/retina-to-blood efflux transport of p-aminohippuric acid, benzylpen-icillin, and 6-mercaptopurine.J Pharmacol Exp Ther 329: 87-93, 2009.
97. Hosoyamada M, Takiue Y, Morisaki H, Cheng J, Ikawa M, Okabe M, Morisaki T, Ichida K, Hosoya T, Shibasaki T. Establishment and analysis of SLC22A12 (URAT1) knockout mouse. Nucleosides Nucleotides Nucleic Acids29: 314-320, 2010.
98. Hu QH, Jiao RQ, Wang X, Lv YZ, Kong LD. Simiao pill ameliorates urate underex-cretion and renal dysfunction in hyperuricemic mice.J Ethnopharmacol 128: 685-692, 2010.
99. Huang ZL, Urade Y, Hayaishi O. Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr Opin Pharmacol7: 33-38, 2007.
100. Hwang JS, Park EY, Kim WY, Yang CW, Kim J. Expression of OAT1 and OAT3 in differentiating proximal tubules of the mouse kidney. Histol Histopathol25: 33-44, 2010.
101. Iacobucci I, Lonetti A, Candoni A, Sazzini M, Papayannidis C, Formica S, Ottaviani E, Ferrari A, Michelutti A, Simeone E, Astolfi A, Abbenante MC, Parisi S, Cattina F, Malagola M, Russo D, Damiani D, Gherlinzoni F, Gottardi M, Baccarani M, Fanin R, Martinelli G. Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. Pharmacogenomics J 13: 335-341, 2012.
102. Imai S, Kikuchi R, Kusuhara H, Sugiyama Y. DNAmethylationand histone modification profiles of mouse organic anion transporting polypeptides. Drug Metab Dispos41: 72-78, 2013.
103. Imamura Y, Murayama N, Okudaira N, Kurihara A, Okazaki O, Izumi T, Inoue K, Yuasa H, Kusuhara H, Sugiyama Y. Prediction of fluoroquinolone-induced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion. Clin Pharmacol Ther89: 81-88, 2011.
104. Ingelman-Sundberg M, Zhong XB, Hankinson O, Beedanagari S, Yu AM, Peng L, Osawa Y. Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport. Drug Metab Dispos41: 1725-1731, 2013.
105. Irukayama-Tomobe Y, Tanaka H, Yokomizo T, Hashidate-Yoshida T, Yanagisawa M, Sakurai T. Aromatic D-amino acids act as chemoattractant factors for human leukocytes through a G protein-coupled receptor, GPR109B. Proc Natl Acad Sci USA 106: 3930-3934, 2009.
106. Ito S, Alcorn J. Xenobiotic transporter expression and function in the human mammary gland. Adv Drug Deliv Rev55: 653-665, 2003.
107. Jacobs LF. From chemotaxis to the cognitive map: the function of olfaction. Proc Natl Acad Sci USA 109 Suppl 1: 10693-10700,2012.
108. Jacobsson JA, Haitina T, Lindblom J, Fredriksson R. Identification of six putative human transporters with structural similarity to the drug transporter SLC22 family. Genomics90: 595-609, 2007.
109. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 Suppl: 245-254, 2003.
110. Jang WC, Nam YH, Ahn YC, Park SM, Yoon IK, Choe JY, Park SH, Her M, Kim SK. G109T polymorphism of SLC22A12 gene is associated with serum uric acid level, but not with metabolic syndrome. Rheumatol Int32: 2257-2263, 2012.
111. Jung KY, Takeda M, Kim DK, Tojo A, Narikawa S, Yoo BS, Hosoyamada M, Cha SH, Sekine T, Endou H. Characterization of ochratoxin A transport by human organic anion transporters. Life Sci69: 2123-2135, 2001.
112. Kaler G, Truong DM, Khandelwal A, Nagle M, Eraly SA, Swaan PW, Nigam SK. Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members. J Biol Chem282: 23841-23853, 2007.
113. Kaler G, Truong DM, Sweeney DE, Logan DW, Nagle M, Wu W, Eraly SA, Nigam SK. Olfactory mucosa-expressed organic anion transporter, Oat6, manifests high affinity interactions with odorant organic anions. Biochem Biophys Res Commun351: 872-876, 2006.
114. Karns R, Zhang G, Sun G, Rao Indugula S, Cheng H, Havas-Augustin D, Novokmet N, Rudan D, Durakovic Z, Missoni S, Chakraborty R, Rudan P, Deka R. Genome-wide association of serum uric acid concentration: replication of sequence variants in an island population of the Adriatic coast of Croatia. Ann Hum Genet76: 121-127, 2012.
115. Kato Y, Sai Y, Yoshida K, Watanabe C, Hirata T, Tsuji A. PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2. Mol Pharmacol67: 734-743, 2005.
116. Kazama I, Matsubara M, Kanai Y, Hatano R, Asano S, Endo Y, Toyama H, Ejima Y, Kurosawa S, Maruyama Y. Decreased expression of a novel prostaglandin transporter, OAT-PG, facilitates renocortical PGE2accumulation during rat pregnancy. Gynecol Obstet Invest76: 163-170, 2013.
117. Kikuchi R, Kusuhara H, Hattori N, Kim I, Shiota K, Gonzalez FJ, Sugiyama Y. Regulation of tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1 alpha/beta and DNA methylation. Mol Pharmacol72: 1619-1625, 2007.
118. Kikuchi R, Kusuhara H, Hattori N, Shiota K, Kim I, Gonzalez FJ, Sugiyama Y. Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1alpha/beta and DNA methylation. Mol Pharmacol70: 887-896, 2006.
119. Kimura H, Takeda M, Narikawa S, Enomoto A, Ichida K, Endou H. Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J Pharmacol Exp Ther301: 293-298, 2002.
120. Kiselyuk A, Lee SH, Farber-Katz S, Zhang M, Athavankar S, Cohen T, Pinkerton AB, Ye M, Bushway P, Richardson AD, Hostetler HA, Rodriguez-Lee M, Huang L, Span-gler B, Smith L, Higginbotham J, Cashman J, Freeze H, Itkin-Ansari P, Dawson MI, Schroeder F, Cang Y, Mercola M, Levine F. HNF4alpha antagonists discovered by a high-throughput screen for modulators of the human insulin promoter. Chem Biol19: 806-818, 2012.
121. Kittayaruksakul S, Soodvilai S, Asavapanumas N, Muanprasat C, Chatsudthipong V. Liver X receptor activation downregulates organic anion transporter 1 (OAT1) in the renal proximal tubule. Am J Physiol Renal Physiol302: F552-F560, 2012.
122. Klahr S, Buerkert J, Purkerson ML. Role ofdietary factors in the progression of chronic renal disease. Kidney Int24: 579-587, 1983.
123. Klein K, Jungst C, Mwinyi J, Stieger B, Krempler F, Patsch W, Eloranta JJ, Kullak-Ublick GA. The human organic anion transporter genes OAT5 and OAT7 are transactivated by hepatocyte nuclear factor-1alpha (HNF-1alpha). Mol Pharm78: 1079-1087, 2010.
124. Kobayashi Y, Ohshiro N, Sakai R, Ohbayashi M, Kohyama N, Yamamoto T. Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]). J Pharm Pharmacol57: 573-578, 2005.
125. Kobayashi Y, Ohshiro N, Shibusawa A, Sasaki T, Tokuyama S, Sekine T, Endou H, Yamamoto T. Isolation, characterization and differential gene expression of multispe-cific organic anion transporter 2 in mice. Mol Pharmacol62: 7-14, 2002.
126. Kobayashi Y, Ohshiro N, Tsuchiya A, Kohyama N, Ohbayashi M, Yamamoto T. Renal transport of organic compounds mediated by mouse organic anion transporter 3 (mOat3): further substrate specificity of mOat3. Drug Metab Dispos32: 479-483, 2004.
127. Koepsell H. The SLC22 family with transporters of organic cations, anions and zwit-terions. Mol Aspects Med34: 413-435, 2013.
128. Koh AS, Simmons-Willis TA, Pritchard JB, Grassl SM, Ballatori N. Identification of a mechanism by which the methylmercury antidotes N-acetylcysteine and dimercap-topropanesulfonate enhance urinary metal excretion: transport by the renal organic anion transporter-1. Mol Pharmacol62: 921-926, 2002.
129. Kojima R, Sekine T, Kawachi M, Cha SH, Suzuki Y, Endou H. Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J Am Soc Nephrol13: 848-857, 2002.
130. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, Mangino M, Albrecht E, Wallace C, Farrall M, Johansson A, Nyholt DR, Aulchenko Y, Beckmann JS, Bergmann S, Bochud M, Brown M, Campbell H, Connell J, Dominiczak A, Homuth G, Lamina C, McCarthy MI, Meitinger T, Mooser V, Munroe P, Nauck M, Peden J, Prokisch H, Salo P, Salomaa V, Samani NJ, Schlessinger D, Uda M, Volker U, Waeber G, Waterworth D, Wang-Sattler R, Wright AF, Adamski J, Whitfield JB, Gyllensten U, Wilson JF, Rudan I, Pramstaller P, Watkins H, Doering A, Wichmann HE, Spector TD, Peltonen L, Volzke H, Nagaraja R, Vollenweider P, Caulfield M, Illig T, Gieger C. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet5: e1000504, 2009.
131. Kouznetsova VL, Tsigelny IF, Nagle MA, Nigam SK. Elucidation of common pharma-cophores from analysis of targeted metabolites transported by the multispecific drug transporter-Organic anion transporter1 (Oat1). Bioorg Med Chem19: 3320-3340, 2011.
132. Kusch-Poddar M, Drewe J, Fux I, Gutmann H. Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood-brain barrier. Brain Res1064: 21-31, 2005.
133. Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kanai Y, Endou H. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem274: 13675-13680, 1999.
134. Kuznetsov G, Nigam SK. Folding of secretory and membrane proteins. N Engl J Med339: 1688-1695, 1998.
135. Kwak JO, Kim HW, Oh KJ, Ko CB, Park H, Cha SH. Characterizationofmouse organic anion transporter 5 as a renal steroid sulfate transporter. J Steroid Biochem Mol Biol97: 369-375, 2005.
136. Lamhonwah AM, Mai L, Chung C, Lamhonwah D, Ackerley C, Tein I. Upregulation of mammary gland OCTNs maintains carnitine homeostasis in suckling infants. BiochemBiophys Res Commun404: 1010-1015, 2011.
137. Li S, Zhang Q, You G. Three ubiquitination sites of organic anion transporter-1 synergistically mediate protein kinase C-dependent endocytosis of the transporter. Mol Pharm84: 139-146, 2013.
138. Ljubojevic M, Balen D, Breljak D, Kusan M, Anzai N, Bahn A, Burckhardt G, Sabolic I. Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones. Am J Physiol Renal Physiol292: F361-F372, 2007.
139. Ljubojevic M, Herak-Kramberger CM, Hagos Y, Bahn A, Endou H, Burckhardt G, Sabolic I. Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am J Physiol Renal Physiol287: F124-F138, 2004.
140. Ljungberg MC, Ali YO, Zhu J, Wu CS, Oka K, Zhai RG, Lu HC. CREB-activity and nmnat2 transcription are downregulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopa-thy. Hum Mol Genet21: 251-267, 2012.
141. Lopez-Lopez E, Ballesteros J, Pinan MA, Sanchez de Toledo J, Garcia de Andoin N, Garcia-Miguel P, Navajas A, Garcia-Orad A. Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia. Pharmacogenet Genomics23: 53-61, 2013.
142. Lopez-Nieto CE, Nigam SK. Selective amplification of protein-coding regions of large sets of genes using statistically designed primer sets. Nat Biotechnol14: 857-861, 1996.
143. Lopez-Nieto CE, You G, Barros EJG, Beier DR, Nigam SK. Molecular cloning and characterization of a novel transporter protein with very high expression in the kidney (Abstract). J Am Soc Nephrol7: 1301, 1996.
144. Lopez-Nieto CE, You G, Bush KT, Barros EJ, Beier DR, Nigam SK. Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. J Biol Chem272: 6471-6478, 1997.
145. Lopez-Nieto CE, You G, Bush KT, Barros EJ, Beier DR, Nigam SK. Mus musculus kidney-specific transport protein mRNA. GenBank1996 www.ncbi.nlm.nih.gov.
146. Macfarlane GT, Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int95: 50-60, 2012.
147. Maher JM, Slitt AL, Callaghan TN, Cheng X, Cheung C, Gonzalez FJ, Klaassen CD. Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha. Biochem Pharmacol72: 512-522, 2006.
148. Mann DL. Hands-On Systematic Innovation. Ieper, Belgium: CREAX Press, 2002, p. 470.
149. Martovetsky G, Tee JB, Nigam SK. Hepatocyte nuclear factors 4a and 1a (Hnf4a and Hnf1a) regulate kidney developmental expression of drug-metabolizing enzymes and drug transporters. Mol Pharmacol84: 808-823, 2013.
150. Masereeuw R, van den Bergh EJ, Bindels RJ, Russel FG. Characterization of fluorescein transport in isolated proximal tubular cells of the rat: evidence for mitochondrial accumulation. J Pharmacol Exp Ther269: 1261-1267, 1994.
151. Mathers JC, McKay JA. Epigenetics: potential contribution to fetal programming. Adv Exp Med Biol646: 119-123, 2009.
152. Matsumura H, Honda K, Choi WS, Inoue S, Sakai T, Hayaishi O. Evidence that brain prostaglandin E2is involved in physiological sleep-wake regulation in rats. Proc Natl Acad Sci USA86: 5666-5669, 1989.
153. McAdams-Demarco MA, Maynard JW, Baer AN, Kao LW, Kottgen A, Coresh J. A urate gene-by-diuretic interaction and gout risk in participants with hypertension: results from the ARIC study. Ann Rheum Dis72: 701-706, 2013.
154. Meeks JP, Arnson HA, Holy TE. Representation and transformation of sensory information in the mouse accessory olfactory system. Nat Neurosci13: 723-730, 2010.
155. Miller DS, Stewart DE, Pritchard JB. Intracellular compartmentation of organic anions within renal cells. Am J Physiol Regul Integr Comp Physiol264: R882-R890, 1993.
156. Miyajima M, Kusuhara H, Fujishima M, Adachi Y, Sugiyama Y. Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepi-androsterone sulfate, across the blood-brain barrier in mice. Drug Metab Dispos39: 814-819, 2011.
157. Miyazaki H, Anzai N, Ekaratanawong S, Sakata T, Shin HJ, Jutabha P, Hirata T, He X, Nonoguchi H, Tomita K, Kanai Y, Endou H. Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins. J Am Soc Nephrol16: 3498-3506, 2005.
158. Mizuno N, Takahashi T, Iwase Y, Kusuhara H, Niwa T, Sugiyama Y. Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edara-vone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate. Drug Metab Dispos35: 1429-1434, 2007.
159. Moller JV, Sheikh MI. Renal organic anion transport system: pharmacological, physiological, and biochemical aspects. Pharmacol Rev34: 315-358, 1982.
160. Monte JC, Nagle MA, Eraly SA, Nigam SK. Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa. Biochem Biophys Res Commun323: 429-436, 2004.
161. Mori K, Ogawa Y, Ebihara K, Aoki T, Tamura N, Sugawara A, Kuwahara T, Ozaki S, Mukoyama M, Tashiro K, Tanaka I, Nakao K. Kidney-specific expression of a novel mouse organic cation transporter-like protein. FEBS Lett417: 371-374, 1997.
162. Mori S, Takanaga H, Ohtsuki S, Deguchi T, Kang YS, Hosoya K, Terasaki T. Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J Cereb Blood Flow Metab23: 432-440, 2003.
163. Morrissey KM, Wen CC, Johns SJ, Zhang L, Huang SM, Giacomini KM. The UCSF-FDA TransPortal: a public drug transporter database. Clin Pharmacol Ther92: 545-546, 2012.
164. Motojima M, Hosokawa A, Yamato H, Muraki T, Yoshioka T. Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake. Br J Pharmacol135: 555-563, 2002.
165. Mount DB. The kidney in hyperuricemia and gout. Curr Opin Nephrol Hypertens22: 216-223, 2013.
166. Mount DB, Kwon CY, Zandi-Nejad K. Renal urate transport. Rheum Dis Clin North Am32: 313-331, 2006.
167. Mulla H. Understanding developmental pharmacodynamics: importance for drug development and clinical practice. Paediatr Drugs12: 223-233,2010.
168. Nagle M, Truong DM, Bhatnagar V, Kaler G, Bush KT, Wu W, Eraly SA, Nigam SK. Organic Anion Transporters. In: Drug Transporters: Molecular Characterization and Role in Drug Disposition, edited by You G, Morris ME. Hoboken, NJ: Wiley, 2006, p. 51-73.
169. Nagle MA, Truong DM, Dnyanmote AV, Ahn SY, Eraly SA, Wu W, Nigam SK. Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling. J Biol Chem286: 243-251, 2011.
170. Nagle MA, Wu W, Eraly SA, Nigam SK. Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue. Neurosci Lett534: 133-138,2013.
171. Nakakariya M, Shima Y, Shirasaka Y, Mitsuoka K, Nakanishi T, Tamai I. Organic anion transporter OAT1 is involved in renal handling of citrulline. Am J Physiol Renal Physiol 297: F71-F79, 2009.
172. Naud J, Michaud J, Boisvert C, Desbiens K, Leblond FA, Mitchell A, Jones C, Bon-nardeaux A, Pichette V. Down-regulation of intestinal drug transporters in chronic renal failure in rats. J Pharmacol Exp Ther320: 978-985, 2007.
173. Naud J, Michaud J, Leblond FA, Lefrancois S, Bonnardeaux A, Pichette V. Effects of chronic renal failure on liver drug transporters. Drug Metab Dispos36: 124-128,2008.
174. Naud J, Nolin TD, Leblond FA, Pichette V. Current understanding of drug disposition in kidney disease. J Clin Pharmacol52: 10S-22S, 2012.
175. Nevitt GA. Sensory ecology on the high seas: the odor world of the procellariiform seabirds. J Exp Biol211:1706-1713, 2008.
176. Nigam SK, Bhatnagar V. How much do we know about drug handling by SLCand ABC drug transporters in children. Clin Pharmacol Ther94: 27-29, 2013.
177. Nigam SK, Bush KT, Bhatnagar V. Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues. Nat Clin Pract Nephrol3: 443-448, 2007.
178. Nishiwaki T, Daigo Y, Tamari M, Fujii Y, Nakamura Y. Molecular cloning, mapping, and characterization of two novel human genes, ORCTL3 and ORCTL4, bearing homology to organic-cation transporters. Cytogenet Cell Genet 83: 251-255, 1998.
179. Niwa T, Tsukushi S, Ise M, Miyazaki T, Tsubakihara Y, Owada A, Shiigai T. Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients. Miner Electrolyte Metab23: 179-184, 1997.
180. Nodari F, Hsu FF, Fu X, Holekamp TF, Kao LF, Turk J, Holy TE. Sulfated steroids as natural ligands of mouse pheromone-sensing neurons. J Neurosci28: 6407-6418, 2008.
181. Nolin TD. Altered nonrenal drug clearance in ESRD. Curr Opin Nephrol Hypertens17: 555-559, 2008.
182. Nozaki Y, Kusuhara H, Kondo T, Hasegawa M, Shiroyanagi Y, Nakazawa H, Okano T, Sugiyama Y. Characterization of the uptake of organic anion transporter (OAT) 1 and OAT3 substrates by human kidney slices. J Pharmacol Exp Ther321: 362-369, 2007.
183. Ogasawara K, Terada T, Asaka J, Katsura T, Inui K. Hepatocyte nuclear factor-4a regulates the human organic anion transporter 1 gene in the kidney. Am J Physiol Renal Physiol292: F1819-F1826, 2007.
184. Ose A, Ito M, Kusuhara H, Yamatsugu K, Kanai M, Shibasaki M, Hosokawa M, Schuetz JD, Sugiyama Y. Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4). Drug Metab Dispos 37: 315-321, 2009.
185. Palmieri F. The mitochondrial transporterfamily SLC25: identification, properties and physiopathology. Mol Aspects Med34: 465-484, 2013.
186. Patnaik PR. Synthesizing cellular intelligence and artificial intelligence for biopro-cesses. Biotechnol Adv24: 129-133, 2006.
187. Pavlova A, Sakurai H, Leclercq B, Beier DR, Yu AS, Nigam SK. Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct. Am J Physiol Renal Physiol278: F635-F643, 2000.
188. Perry JL, Dembla-Rajpal N, Hall LA, Pritchard JB. A three-dimensional model of human organic anion transporter 1: aromatic amino acids required for substrate transport. J Biol Chem281: 38071-38079, 2006.
189. Pham TX, Lee J. Dietary regulation of histone acetylases and deacetylases for the prevention of metabolic diseases. Nutrients4: 1868-1886, 2012.
190. Pluznick JL, Caplan MJ. Novel sensory signaling systems in the kidney. Curr Opin Nephrol Hypertens21: 404-409, 2012.
191. Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, Brunet I, Wan LX, Rey F, Wang T, Firestein SJ, Yanagisawa M, Gordon JI, Eichmann A, Peti-Peterdi J, Caplan MJ. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci USA110: 4410-4415, 2013.
192. Pombrio JM, Giangreco A, Li L, Wempe MF, Anders MW, Sweet DH, Pritchard JB, Ballatori N. Mercapturic acids (N-acetylcysteine S-conjugates) as endogenous substrates for the renal organic anion transporter-1. Mol Pharmacol60: 1091-1099, 2001.
193. Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, Yaniv M. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketo-nuria, and renal Fanconi syndrome. Cell84: 575-585, 1996.
194. Pritchard JB. Coupled transport of p-aminohippurate by rat kidney basolateral membrane vesicles. Am J Physiol Renal Fluid Electrolyte Physiol255: F597-F604, 1988.
195. Pritchard JB, Sweet DH, Miller DS, Walden R. Mechanism of organic anion transport across the apical membrane of choroid plexus. J Biol Chem274: 33382-33387, 1999.
196. Purohit A, Woo LW, Potter BV. Steroid sulfatase: a pivotal player inestrogen synthesis and metabolism. Mol Cell Endocrinol340: 154-160, 2011.
197. Rabe T, Hosch R, Runnebaum B. Diagnosis of intrauterine fetal growth retardation (IUGR) and placental insufficiency by a dehydroepiandrosterone sulfate (DHAS) loading test. Biol Res Pregnancy Perinatol4: 130-136, 1983.
198. Rammelkamp CH, Keefer CS. The absorption, excretion, and distribution of penicillin. J Clin Invest22: 425-437, 1943.
199. Reddy VS, Saier MH Jr. The major facilitator superfamily (MFS) revisited. FEBS J279: 2036-2046, 2012.
200. Rehmann H, Wittinghofer A, Bos JL. Capturing cyclic nucleotides in action: snapshots from crystallographic studies. Nat Rev Mol Cell Biol8: 63-73, 2007.
201. Reimer RJ. SLC17: a functionally diverse family of organic anion transporters. Mol Aspects Med34: 350-359, 2013.
202. Reimer RJ, Edwards RH. Organic anion transport is the primary function of the SLC17/type I phosphate transporter family. Pfl¨ugers Arch447: 629-635, 2004.
203. Rizwan AN, Burckhardt G. Organic anion transporters of the SLC22 family: biophar-maceutical, physiological, and pathological roles. Pharm Res24: 450-470, 2007.
204. Rosines E, Sampogna RV, Johkura K, Vaughn DA, Choi Y, Sakurai H, Shah MM, Nigam SK. Staged in vitro reconstitution and implantation of engineered rat kidney tissue. Proc Natl Acad Sci USA104: 20938-20943, 2007.
205. Roth M, Obaidat A, Hagenbuch B. OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol165: 1260-1287, 2012.
206. Sailaja BS, Cohen-Carmon D, Zimmerman G, Soreq H, Meshorer E. Stress-induced epigenetic transcriptional memory of acetylcholinesterase by HDAC4. Proc Natl Acad Sci USA109: E3687-3695, 2012.
207. Saito H. Pathophysiological regulation of renal SLC22A organic ion transporters in acute kidney injury: pharmacological and toxicological implications. Pharmacol Ther125: 79-91, 2010.
208. Sakiyama M, Matsuo H, Shimizu S, Nakashima H, Nakayama A, Chiba T, Naito M, Takada T, Suzuki H, Hamajima N, Ichida K, Shimizu T, Shinomiya N. A common variant of organic anion transporter 4 (OAT4/SLC22A11) gene is associated with renal underexcretion type gout. Drug Metab Pharmacokinet29: 208-210, 2014.
209. Sauvant C, Holzinger H, Gekle M. Prostaglandin E2inhibits its own renal transport by downregulation of organic anion transporters rOAT1 and rOAT3.J Am Soc Nephrol 17: 46-53, 2006.
210. Schaeffeler E, Hellerbrand C, Nies AT, Winter S, Kruck S, Hofmann U, van der Kuip H, Zanger UM, Koepsell H, Schwab M. DNA methylation is associated with down-regulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma. Genome Med3: 82, 2011.
211. Schnabolk GW, Gupta B, Mulgaonkar A, Kulkarni M, Sweet DH. Organic anion transporter 6 (Slc22a20) specificity and Sertoli cell-specific expression provide new insight on potential endogenous roles. J Pharmacol Exp Ther334: 927-935, 2010.
212. Schnabolk GW, Youngblood GL, Sweet DH. Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20). Am J Physiol Renal Physiol291: F314-F321, 2006.
213. Schoog M, Arning R. Effect of benemid on p-aminohippuric acid blood level. Arzneimit-telforschung3: 377-379, 1953.
214. Schroeder JC, Dinatale BC, Murray IA, Flaveny CA, Liu Q, Laurenzana EM, Lin JM, Strom SC, Omiecinski CJ, Amin S, Perdew GH. The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry49: 393-400, 2010.
215. Secky L, Svoboda M, Klameth L, Bajna E, Hamilton G, Zeillinger R, Jager W, Thalhammer T. The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors. J Drug Deliv2013: 957605, 2013.
216. Sharma K, Karl B, Mathew AV, Gangoiti JA, Wassel CL, Saito R, Pu M, Sharma S, You YH, Wang L, Diamond-Stanic M, Lindenmeyer MT, Forsblom C, Wu W, Ix JH, Ideker T, Kopp JB, Nigam SK, Cohen CD, Groop PH, Barshop BA, Natarajan L, Nyhan WL, Naviaux RK. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol 24: 1901-1912, 2013.
217. Shimada H, Moewes B, Burckhardt G. Indirect coupling to Na+ of p-aminohippuric acid uptake into rat renal basolateral membrane vesicles. Am J Physiol Renal Fluid Electrolyte Physiol253: F795-F801, 1987.
218. Shin HJ, Anzai N, Enomoto A, He X, Kim do K, Endou H, Kanai Y. Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate. Hepatology 45: 1046-1055, 2007.
219. Shiraya K, Hirata T, Hatano R, Nagamori S, Wiriyasermkul P, Jutabha P, Matsubara M, Muto S, Tanaka H, Asano S, Anzai N, Endou H, Yamada A, Sakurai H, Kanai Y. A novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubules. J Biol Chem 285: 22141-22151, 2010.
220. Shuster DL, Bammler TK, Beyer RP, Macdonald JW, Tsai JM, Farin FM, Hebert MF, Thummel KE, Mao Q. Gestational age-dependent changes in gene expression of metabolic enzymes and transporters in pregnant mice. Drug Metab Dispos 41: 332-342, 2013.
221. Silva P, Torretti J, Hayslett JP, Epstein FH. Relation between Na-K-ATPase activity and respiratory rate in the rat kidney. AmJ Physiol230: 1432-1438, 1976.
222. Simonson GD, Vincent AC, Roberg KJ, Huang Y, Iwanij V. Molecular cloning and characterization of a novel liver-specific transport protein. J Cell Sci107: 1065-1072, 1994.
223. Singh BN, Shankar S, Srivastava RK. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol82: 1807-1821,2011.
224. Smith CA, Want EJ, O’Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem78: 779-787, 2006.
225. Smith HW, Finkelstein N, Aliminosa L, Crawford B, Graber M. The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 24: 388-404, 1945.
226. Stuart RO, Bush KT, Nigam SK. Changes in global gene expression patterns during development and maturation of the rat kidney. Proc Natl Acad Sci USA98: 5649-5654, 2001.
227. Sugawara M, Mochizuki T, Takekuma Y, Miyazaki K. Structure-affinity relationship in the interactions of human organic anion transporter 1 with caffeine, theophylline, theobromine and their metabolites. Biochim Biophys Acta1714: 85-92, 2005.
228. Sugiyama D, Kusuhara H, Shitara Y, Abe T, Meier PJ, Sekine T, Endou H, Suzuki H, Sugiyama Y. Characterization of the efflux transport of 17beta-estradiol-D-17beta-glucuronide from the brain across the blood-brain barrier.J Pharmacol Exp Ther 298: 316-322, 2001.
229. Sun W, Wu RR, van Poelje PD, Erion MD. Isolation of a family of organic anion transporters from human liver and kidney. Biochem Biophys Res Commun283: 417-422, 2001.
230. Sweeney DE, Vallon V, Rieg T, Wu W, Gallegos TF, Nigam SK. Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney. Mol Pharmacol 80: 147-154, 2011.
231. Sweet DH, Bush KT, Nigam SK. The organic anion transporter family: from physiology to ontogeny and the clinic. Am J Physiol Renal Physiol281: F197-F205, 2001.
232. Sweet DH, Chan LM, Walden R, Yang XP, Miller DS, Pritchard JB. Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient. Am J Physiol Renal Physiol284: F763-F769, 2003.
233. Sweet DH, Eraly SA, Vaughn DA, Bush KT, Nigam SK. Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models. Kidney Int69: 837-845, 2006.
234. Sweet DH, Miller DS, Pritchard JB, Fujiwara Y, Beier DR, Nigam SK. Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 [Oat3 (Slc22a8)] knockout mice.J Biol Chem 277: 26934-26943, 2002.
235. Sweet DH, Wolff NA, Pritchard JB. Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney. J Biol Chem 272: 30088-30095, 1997.
236. Sykes D, Sweet DH, Lowes S, Nigam SK, Pritchard JB, Miller DS. Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice. Am J Physiol Renal Physiol286: F972-F978, 2004.
237. Tabara Y, Kohara K, Kawamoto R, Hiura Y, Nishimura K, Morisaki T, Kokubo Y, Okamura T, Tomoike H, Iwai N, Miki T. Association of four genetic loci with uric acid levels and reduced renal function: theJ-SHIPP Suita study. Am J Nephrol 32: 279-286, 2010.
238. Tachikawa M, Ozeki G, Higuchi T, Akanuma S, Tsuji K, Hosoya K. Role of the blood-cerebrospinal fluid barrier transporter as a cerebral clearance system for prostaglandin E2produced in the brain.J Neurochem 123: 750-760, 2012.
239. Tachikawa M, Tsuji K, Yokoyama R, Higuchi T, Ozeki G, Yashiki A, Akanuma S, Hayashi K, Nishiura A, Hosoya K. A clearance system for prostaglandin D2, a sleep-promoting factor, in cerebrospinal fluid: role of the blood-cerebrospinal barriertrans-porters.J Pharmacol Exp Ther 343: 608-616, 2012.
240. Tahara H, Shono M, Kusuhara H, Kinoshita H, Fuse E, Takadate A, Otagiri M, Sugiyama Y. Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney. Pharm Res22: 647-660, 2005.
241. Takeda M, Khamdang S, Narikawa S, Kimura H, Hosoyamada M, Cha SH, Sekine T, Endou H. Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther302: 666-671, 2002.
242. Takemiya T. Prostaglandin E2produced by microsomal prostaglandin E synthase-1 regulates the onset and the maintenance of wakefulness. Neurochem Int 59: 922-924, 2011.
243. Takeuchi F, Yamamoto K, Isono M, Katsuya T, Akiyama K, Ohnaka K, Rakugi H, Yamori Y, Ogihara T, Takayanagi R, Kato N. Genetic impact on uric acid concentration and hyperuricemia in the Japanese population. J Atheroscler Thromb20: 351-367, 2013.
244. Taleb O, Maammar M, Brumaru D, Bourguignon JJ, Schmitt M, Klein C, Kemmel V, Maitre M, Mensah-Nyagan AG. Xanthurenic acid binds to neuronal G-protein-cou-pled receptors that secondarily activate cationic channels in the cell line NCB-20. PloS One7: e48553, 2012.
245. Thiagarajan RD, Georgas KM, Rumballe BA, Lesieur E, Chiu HS, Taylor D, Tang DT, Grimmond SM, Little MH. Identification of anchor genes during kidney development defines ontological relationships, molecular subcompartments and regulatory pathways. PloS One6: e17286, 2011.
246. Thiebaud N, Menetrier F, Belloir C, Minn AL, Neiers F, Artur Y, Le Bon AM, Heydel JM. Expression and differential localization of xenobiotic transporters in the rat olfactory neuro-epithelium. Neurosci Lett505: 180-185, 2011.
247. Thiebaud N, Sigoillot M, Chevalier J, Artur Y, Heydel JM, Le Bon AM. Effects of typical inducers on olfactory xenobiotic-metabolizing enzyme, transporter, and transcription factor expression in rats. Drug Metab Dispos38: 1865-1875, 2010.
248. Tin A, Woodward OM, Kao WH, Liu CT, Lu X, Nalls MA, Shriner D, Semmo M, Akylbekova EL, Wyatt SB, Hwang SJ, Yang Q, Zonderman AB, Adeyemo AA, Palmer C, Meng Y, Reilly M, Shlipak MG, Siscovick D, Evans MK, Rotimi CN, Flessner MF, Kottgen M, Cupples LA, Fox CS, Kottgen A. Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Hum Mol Genet20: 4056-4068, 2011.
249. Torres AM, Dnyanmote AV, Bush KT, Wu W, Nigam SK. Deletion of multispecific organic anion transporter Oat1/Slc22a6 protects against mercury-induced kidney injury. J Biol Chem286: 26391-26395, 2011.
250. Truong DM, Kaler G, Khandelwal A, Swaan PW, Nigam SK. Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination. J Biol Chem283: 8654-8663, 2008.
251. Tsigelny IF, Greenberg J, Kouznetsova V, Nigam SK. Modeling of glycerol-3-phos-phate transporter suggests a potential ‘tilt’ mechanism involved in its function. J Bioin-form Comput Biol6: 885-904, 2008.
252. Tsigelny IF, Kouznetsova VL, Sweeney DE, Wu W, Bush KT, Nigam SK. Analysis of metagene portraits reveals distinct transitions during kidney organogenesis. Sci Signal1: ra16, 2008.
253. Tsigelny IF, Kovalskyy D, Kouznetsova VL, Balinskyi O, Sharikov Y, Bhatnagar V, Nigam SK. Conformational changes of the multispecific transporter organic anion transporter 1 (OAT1/SLC22A6) suggests a molecular mechanism for initial stages of drug and metabolite transport. Cell Biochem Biophys61: 251-259, 2011.
254. Tsuchida H, Anzai N, Shin HJ, Wempe MF, Jutabha P, Enomoto A, Cha SH, Satoh T, Ishida M, Sakurai H, Endou H. Identification of a novel organic anion transporter mediating carnitine transport in mouse liver and kidney. Cell Physiol Biochem25: 511-522, 2010.
255. Tsujimoto M, Hatozaki D, Shima D, Yokota H, Furukubo T, Izumi S, Yamakawa T, Minegaki T, Nishiguchi K. Influence of serum in hemodialysis patients on the expression of intestinal and hepatic transporters for the excretion of pravastatin. Ther Apher Dial16: 580-587, 2012.
256. Uehara I, Kimura T, Tanigaki S, Fukutomi T, Sakai K, Shinohara Y, Ichida K, Iwashita M, Sakurai H. Paracellular route is the major urate transport pathway across the blood-placental barrier. Physiol Rep2: e12013, 2014.
257. Ueo H, Motohashi H, Katsura T, Inui K. Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochem Pharmacol70: 1104-1113, 2005.
258. Ugele B, Bahn A, Rex-Haffner M. Functional differences in steroid sulfate uptake of organic anion transporter 4 (OAT4) and organic anion transporting polypeptide 2B1 (OATP2B1) in human placenta. J Steroid Biochem Mol Biol111: 1-6, 2008.
259. Ugele B, St-Pierre MV, Pihusch M, Bahn A, Hantschmann P. Characterization and identification of steroid sulfate transporters of human placenta. Am J Physiol Endocrinol Metab284: E390-E398, 2003.
260. Ullrich KJ, Rumrich G. Renal transport mechanisms for xenobiotics: chemicals and drugs. Clin Invest71: 843-848, 1993.
261. Urquhart BL, Kim RB. Blood-brain barrier transporters and response to CNS-active drugs. Eur J Clin Pharmacol65: 1063-1070, 2009.
262. Uwai Y, Motohashi H, Tsuji Y, Ueo H, Katsura T, Inui K. Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3. Biochem Pharmacol74: 161-168, 2007.
263. Uwai Y, Taniguchi R, Motohashi H, Saito H, Okuda M, Inui K. Methotrexate-loxopro-fen interaction: involvement of human organic anion transporters hOAT1 and hOAT3. Drug Metab Pharmacokinet19: 369-374, 2004.
264. Vallon V, Eraly SA, Rao SR, Gerasimova M, Rose M, Nagle M, Anzai N, Smith T, Sharma K, Nigam SK, Rieg T. A role for the organic anion transporter OAT3 in renal creatinine secretion in mice. Am J Physiol Renal Physiol302: F1293-F1299, 2012.
265. Vallon V, Eraly SA, Wikoff WR, Rieg T, Kaler G, Truong DM, Ahn SY, Mahapatra NR, Mahata SK, Gangoiti JA, Wu W, Barshop BA, Siuzdak G, Nigam SK. Organic anion transporter 3 contributes to the regulation of blood pressure. J Am Soc Nephrol19: 1732-1740, 2008.
266. Vallon V, Rieg T, Ahn SY, Wu W, Eraly SA, Nigam SK. Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics. Am J Physiol Renal Physiol294: F867-F873, 2008.
267. Van den Anker JN, Schwab M, Kearns GL. Developmental pharmacokinetics. In: Pediatric Clinical Pharmacology, edited by Seyberth HW, Rane A, Schwab M. Berlin: Springer, 2011, p. 51-75.
268. Van der Harst P, Bakker SJ, de Boer RA, Wolffenbuttel BH, Johnson T, Caulfield MJ, Navis G. Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. Hum Mol Genet19: 387-395, 2010.
269. VanWert AL, Bailey RM, Sweet DH. Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G. Am J Physiol Renal Physiol293: F1332-F1341, 2007.
270. VanWert AL, Gionfriddo MR, Sweet DH. Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology. Biopharm Drug Dispos31: 1-71, 2010.
271. VanWert AL, Sweet DH. Impaired clearance of methotrexate in organic anion transporter 3 (Slc22a8) knockout mice: a gender specific impact of reduced folates. PharmRes25: 453-462, 2008.
272. Villeneuve LM, Reddy MA, Natarajan R. Epigenetics: deciphering its role in diabetes and its chronic complications. Clin Exp Pharmacol Physiol38: 451-459, 2011.
273. Vitetta L, Linnane AW, Gobe GC. From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling. Toxins5: 2042-2057, 2013.
274. Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem281: 22021-22028, 2006.
275. Wang JS, Newport DJ, Stowe ZN, Donovan JL, Pennell PB, DeVane CL. The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient. Drug Metab Rev39: 723-746, 2007.
276. Wang L, Sweet DH. Interaction of natural dietary and herbal anionic compounds and flavonoids with human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11). Evid Based Complement Alternat Med2013: 612527, 2013.
277. Wang Y, Borchert ML, Deluca HF. Identification of the vitamin D receptor in various cells of the mouse kidney. Kidney Int81: 993-1001, 2012.
278. Wegner W, Burckhardt BC, Burckhardt G, Henjakovic M. Male-dominant activation of rat renal organic anion transporter 1 (Oat1) and 3 (Oat3) expression by transcription factor BCL6. PloS One7: e35556, 2012.
279. Wikoff WR, Nagle MA, Kouznetsova VL, Tsigelny IF, Nigam SK. Untargeted metabo-lomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1). J Proteome Res10: 2842-2851, 2011.
280. Wong CC, Botting NP, Orfila C, Al-Maharik N, Williamson G. Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6). Biochem Pharmacol81: 942-949, 2011.
281. Wright AF, Rudan I, Hastie ND, Campbell H. A “complexity” of urate transporters. Kidney Int78: 446-452, 2010.
282. Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev84: 987-1049, 2004.
283. Wu W, Baker ME, Eraly SA, Bush KT, Nigam SK. Analysis of a large cluster of SLC22 transporter genes, including novel USTs, reveals species-specific amplification of subsets of family members. Physiol Genomics38: 116-124, 2009.
284. Wu W, Dnyanmote AV, Nigam SK. Remote communication through Slc and Abc drug transporter pathways: an update on the remote sensing and signaling hypothesis. Mol Pharmacol79: 795-805, 2011.
285. Wu W, Jamshidi N, Eraly SA, Liu HC, Bush KT, Palsson BO, Nigam SK. Multispecific drug transporter slc22a8 (oat3) regulates multiple metabolic and signaling pathways. Drug Metab Dispos41: 1825-1834, 2013.
286. Xu G, Bhatnagar V, Wen G, Hamilton BA, Eraly SA, Nigam SK. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)]. Kidney Int 68: 1491-1499, 2005.
287. Xue X, Gong LK, Maeda K, Luan Y, Qi XM, Sugiyama Y, Ren J. Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I. Mol Pharm 8: 2183-2192, 2011.
288. Yamashita F, Ohtani H, Koyabu N, Ushigome F, Satoh H, Murakami H, Uchiumi T, Nakamura T, Kuwano M, Tsujimoto M, Sawada Y. Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4.J Pharm Pharmacol 58: 1499-1505, 2006.
289. Yang CH, Glover KP, Han X. Characterization of cellular uptake of perfluorooctano-ate via organic anion-transporting polypeptide 1A2, organic anion transporter 4, and urate transporter 1 for their potential roles in mediating human renal reabsorption of perfluorocarboxylates. Toxicol Sci117: 294-302, 2010.
290. Yang J, Kalogerou M, Gallacher J, Sampson JR, Shen MH. Renal tumours in aTsc1 +/ — mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin. Eur J Cancer49: 1479-1490, 2013.
291. Yang Q, Kottgen A, Dehghan A, Smith AV, Glazer NL, Chen MH, Chasman DI, Aspelund T, Eiriksdottir G, Harris TB, Launer L, Nalls M, Hernandez D, Arking DE, Boerwinkle E, Grove ML, Li M, Linda Kao WH, Chonchol M, Haritunians T, Li G, Lumley T, Psaty BM, Shlipak M, Hwang SJ, Larson MG, O’Donnell CJ, Upadhyay A, van Duijn CM, Hofman A, Rivadeneira F, Stricker B, Uitterlinden AG, Pare G, Parker AN, Ridker PM, Siscovick DS, Gudnason V, Witteman JC, Fox CS, Coresh J. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet 3: 523-530, 2010.
292. Yee SW, Nguyen AN, Brown C, Savic RM, Zhang YC, Castro RA, Cropp CD, Choi JH, Singh D, Tahara H, Stocker SL, Huang Y, Brett CM, Giacomini KM. Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8).J Pharm Sci 102: 3451-3457,2013.
293. Yokoyama H, Anzai N, Ljubojevic M, Ohtsu N, Sakata T, Miyazaki H, Nonoguchi H, Islam R, Onozato M, Tojo A, Tomita K, Kanai Y, Igarashi T, Sabolic I, Endou H. Functional and immunochemical characterization of a novel organic anion transporter Oat8 (Slc22a9) in rat renal collecting duct. Cell Physiol Biochem 21: 269-278, 2008.
294. You G. Membrane transporters in drug disposition. Pharm Res25: 441-443, 2008.
295. Youngblood GL, Sweet DH. Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney. AmJ Physiol Renal Physiol287: F236-F244, 2004.
296. Yun CC, Chen Y, Lang F. Glucocorticoid activation of Na+/H+ exchanger isoform 3 revisited. The roles of SGK1 and NHERF2.J Biol Chem 277: 7676-7683, 2002.
297. Zalups RK. Molecular interactions with mercury in the kidney. Pharmacol Rev52: 113-143, 2000.
298. Zalups RK, Ahmad S. Handling of the homocysteine S-conjugate of methylmercury by renal epithelial cells: role of organic anion transporter 1 and amino acid transporters. J Pharmacol Exp Ther315: 896-904, 2005.
299. Zalups RK, Ahmad S. Homocysteine and the renal epithelial transport and toxicity of inorganic mercury: role of basolateral transporter organic anion transporter 1.J Am Soc Nephrol 15: 2023-2031, 2004.
300. Zhang Q, Hong M, Duan P, Pan Z, Ma J, You G. Organic anion transporter OAT1 undergoes constitutive and protein kinase C-regulated trafficking through adynamin-and clathrin-dependent pathway. J Biol Chem 283: 32570-32579, 2008.
301. Zhang W, Yen GG, He Z. Constrained optimization via artificial immune system. IEEETrans Cybern44: 185-198, 2013.
302. Zhang X, De la Cruz O, Pinto JM, Nicolae D, Firestein S, Gilad Y. Characterizing the expression of the human olfactory receptor gene family using a novel DNA microar-ray. Genome Biol8: R86, 2007.
303. Zhang XJ, Lai TB, Kong RY. Biology of fluoro-organic compounds. Top Curr Chem 308: 365-404, 2012.
304. Zhao YY. Metabolomics in chronic kidney disease. Clin Chim Acta422: 59-69, 2013.
305. Zhou F, Illsley NP, You G. Functional characterization of a human organic anion transporter hOAT4 in placental BeWo cells. Eur J Pharm Sci27: 518-523, 2006.
306. Zhou F, Xu W, Tanaka K, You G. Comparison of the interaction of human organic anion transporter hOAT4 with PDZ proteins between kidney cells and placental cells. Pharm Res25: 475-480, 2008.
307. Zlender V, Breljak D, Ljubojevic M, Flajs D, Balen D, Brzica H, Domijan AM, Peraica M, Fuchs R, Anzai N, Sabolic I. Low doses of ochratoxin A upregulate the protein expression of organic anion transporters Oat1, Oat2, Oat3 and Oat5 in rat kidney cortex. Toxicol Appl Pharmacol239: 284-296, 2009.